Revolutionizing the Canavan Disease Treatment Market
Canavan disease, a rare and fatal neurological disorder caused by a mutation in the ASPA gene, leads to a deficiency in the enzyme aspartoacylase.
Article Date
June 24, 2025
This article is featured on another website.
Go to article
January 28, 2026
Navigating Clinical Trials in the Philippines and Malaysia: Insights and Opportunities
Due to a combination of large, diverse populations, effective healthcare infrastructure, and evolving regulatory and…
January 28, 2026
Navigating Clinical Trials in the Philippines and Malaysia: Insights and Opportunities
Due to a combination of large, diverse populations, effective healthcare infrastructure, and evolving regulatory and…